The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shnyakin P.G.

Prof. V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia;
Regional Clinical Hospital, Krasnoyarsk, Russia

Gavrilova A.O.

Prof. V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia

Multiple foci of cerebral ischemia in cancer patients with secondary antiphospholipid syndrome

Authors:

Shnyakin P.G., Gavrilova A.O.

More about the authors

Read: 593 times


To cite this article:

Shnyakin PG, Gavrilova AO. Multiple foci of cerebral ischemia in cancer patients with secondary antiphospholipid syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(3‑2):84‑89. (In Russ.)
https://doi.org/10.17116/jnevro202612603284

References:

  1. Miesbach W, Asherson RA, Cervera R, et al. The catastrophic antiphospholipid (Asherson’s) syndrome and malignancies. Autoimmun Rev. 2006; 6:94-97.  https://doi.org/10.1016/j.autrev.2006.06.012
  2. Reinstein E, Shoenfeld Y. Antiphospholipid syndrome and cancer. Clin Rev Allergy Immunol. 2007;32(2):184-187.  https://doi.org/10.1007/s12016-007-0003-1
  3. Bazzan M, Montaruli B, Vaccarino A, et al. Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study. Intern Emerg Med. 2009;4(6):491-495.  https://doi.org/10.1007/s11739-009-0316-6
  4. Kansuttiviwat C, Niprapan P, Tantiworawit A, et al. Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients. PLoS One. 2023;18(1):e0279450. https://doi.org/10.1371/journal.pone.0279450
  5. Mittal P, Quattrocchi G, Tohidi-Esfahani I, et al. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. Int J Stroke. 2023;18(4):383-391.  https://doi.org/10.1177/17474930221150349
  6. Mendes GNN, Morais ABCG, Gioia LC, et al. Neurovascular complications of antiphospholipid syndrome: a narrative review. Complicações neurovasculares da síndrome antifosfolipídeo: uma revisão narrativa. Arq Neuropsiquiatr. 2024;82(12):1-7.  https://doi.org/10.1055/s-0044-1793932
  7. Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258-1270. https://doi.org/10.1136/ard-2023-224609
  8. Bertoletti L, Benhamou Y, Béjot Y, et al. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Rev. 2018;32(4):272-279.  https://doi.org/10.1016/j.blre.2018.01.002
  9. Ricarte IF, Dutra LA, Abrantes FF, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018;27(9):1404-1414. https://doi.org/10.1177/0961203318776110
  10. Sanna G, D’Cruz D, Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am. 2006;32(3):465-490.  https://doi.org/10.1016/j.rdc.2006.05.010
  11. Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med. 2018;378(21):2010-2021. https://doi.org/10.1056/NEJMra1705454
  12. Linnemann B. Antiphospholipid syndrome — an update. Vasa. 2018;47(6): 451-464.  https://doi.org/10.1024/0301-1526/a000723
  13. Fazliakhmetova AG, Bogdanov EI. Ischemic stroke in antiphospholipid syndrome: a clinical case. Innovatsionnye tekhnologii v meditsine. 2015;2(89): 163-165. (In Russ.).
  14. Miyamae T, Kawabe T. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome. J Clin Med. 2021;10(6):1240. https://doi.org/10.3390/jcm10061240
  15. Islam MA, Alam F, Sasongko TH, et al. Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment. Curr Pharm Des. 2016;22(28):4451-4469. https://doi.org/10.2174/1381612822666160527160029
  16. Okuma H, Kitagawa Y. Diagnosis and potential treatment of antiphospholipid syndrome-related mainly on ischemic stroke. Brain Nerve. 2013;65(11): 1319-1332.
  17. Ruiz-Irastorza G, Khamashta MA. Stroke and antiphospholipid syndrome: the treatment debate. Rheumatology (Oxford). 2005;44(8):971-974.  https://doi.org/10.1093/rheumatology/keh666
  18. Yang W, Chung M, Ha J, et al. Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody- related stroke. Sci Rep. 2025;15(1):7282. https://doi.org/10.1038/s41598-025-91739-w

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.